Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1734552258;52259;52260 chr2:178609277;178609276;178609275chr2:179474004;179474003;179474002
N2AB1570447335;47336;47337 chr2:178609277;178609276;178609275chr2:179474004;179474003;179474002
N2A1477744554;44555;44556 chr2:178609277;178609276;178609275chr2:179474004;179474003;179474002
N2B828025063;25064;25065 chr2:178609277;178609276;178609275chr2:179474004;179474003;179474002
Novex-1840525438;25439;25440 chr2:178609277;178609276;178609275chr2:179474004;179474003;179474002
Novex-2847225639;25640;25641 chr2:178609277;178609276;178609275chr2:179474004;179474003;179474002
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGT
  • RefSeq wild type template codon: CCA
  • Domain: Ig-112
  • Domain position: 95
  • Structural Position: 152
  • Q(SASA): 0.1549
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/V None None 1.0 D 0.867 0.817 0.774044466036 gnomAD-4.0.0 6.99481E-07 None None None None N None 0 0 None 0 0 None 0 0 9.11361E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.6078 likely_pathogenic 0.681 pathogenic -0.79 Destabilizing 0.949 D 0.65 neutral D 0.554271242 None None N
G/C 0.8478 likely_pathogenic 0.8894 pathogenic -0.809 Destabilizing 1.0 D 0.825 deleterious D 0.610494372 None None N
G/D 0.9426 likely_pathogenic 0.9535 pathogenic -1.555 Destabilizing 1.0 D 0.859 deleterious D 0.594071402 None None N
G/E 0.9747 likely_pathogenic 0.9812 pathogenic -1.574 Destabilizing 1.0 D 0.871 deleterious None None None None N
G/F 0.9881 likely_pathogenic 0.9902 pathogenic -1.057 Destabilizing 1.0 D 0.878 deleterious None None None None N
G/H 0.9813 likely_pathogenic 0.9864 pathogenic -1.602 Destabilizing 1.0 D 0.839 deleterious None None None None N
G/I 0.9884 likely_pathogenic 0.99 pathogenic -0.262 Destabilizing 1.0 D 0.873 deleterious None None None None N
G/K 0.9853 likely_pathogenic 0.9885 pathogenic -1.296 Destabilizing 1.0 D 0.871 deleterious None None None None N
G/L 0.9799 likely_pathogenic 0.9833 pathogenic -0.262 Destabilizing 1.0 D 0.863 deleterious None None None None N
G/M 0.9883 likely_pathogenic 0.9907 pathogenic -0.102 Destabilizing 1.0 D 0.833 deleterious None None None None N
G/N 0.954 likely_pathogenic 0.966 pathogenic -1.017 Destabilizing 1.0 D 0.834 deleterious None None None None N
G/P 0.9991 likely_pathogenic 0.999 pathogenic -0.397 Destabilizing 1.0 D 0.869 deleterious None None None None N
G/Q 0.9651 likely_pathogenic 0.9728 pathogenic -1.149 Destabilizing 1.0 D 0.884 deleterious None None None None N
G/R 0.9624 likely_pathogenic 0.9694 pathogenic -1.053 Destabilizing 1.0 D 0.877 deleterious D 0.610292568 None None N
G/S 0.5438 ambiguous 0.6203 pathogenic -1.266 Destabilizing 0.999 D 0.813 deleterious D 0.609888959 None None N
G/T 0.9297 likely_pathogenic 0.9446 pathogenic -1.21 Destabilizing 1.0 D 0.874 deleterious None None None None N
G/V 0.9732 likely_pathogenic 0.9775 pathogenic -0.397 Destabilizing 1.0 D 0.867 deleterious D 0.610494372 None None N
G/W 0.9888 likely_pathogenic 0.991 pathogenic -1.548 Destabilizing 1.0 D 0.835 deleterious None None None None N
G/Y 0.9864 likely_pathogenic 0.9894 pathogenic -1.1 Destabilizing 1.0 D 0.873 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.